Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER